Depomedroxyprogesterone acetate for hot flashes

Journal of Pain and Symptom Management

Volumn 24, Issue 6, 2002, Pages 603-607

  Barton, Debra ^a   Loprinzi, Charles ^a   Quella, Susan ^a   Sloan, Jeff ^a   Pruthi, Sandya ^a   Novotny, Paul ^a  

^a MAYO CLINIC   (United States)

Author keywords

Breast cancer survivors; Depomedroxyprogesterone acetate; Hot flashes; Menopause

Indexed keywords

ANDROGEN; MEDROXYPROGESTERONE ACETATE;

ABDOMINAL CRAMP; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; EDEMA; FECES; FEMALE; FINGER NAIL; FLU LIKE SYNDROME; HEADACHE; HEART PALPITATION; HOT FLUSH; HUMAN; HYPERTENSION; INCREASED APPETITE; INSOMNIA; MALE; MUSCLE SPASM; NIGHTMARE; PAIN; PROSTATE CANCER; SIDE EFFECT; SPOTTING; TREATMENT OUTCOME; WEIGHT GAIN;

ADULT; AGED; FEMALE; HOT FLASHES; HUMANS; MALE; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; PROGESTERONE CONGENERS;

EID: 0036962481     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(02)00525-0     Document Type: Article

References (14)

1. Fisher B., Costantino J., Redmond C.et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med. 320:1989;479-484.
2. Carpenter J., Andrykowski M. Menopausal symptoms in breast cancer survivors. Oncol Nurs Forum. 26(8):1999;1311-1317.
3. Charig C., Rundle J. Flushing. long-term side effect of orchiectomy in treatment of prostatic carcinoma Urology. 33(3):1989;175-178.
4. Brosman S. Depo-Provera as a treatment for hot flashes in men on androgen ablation therapy. J Urol 1995;153S:448A.
5. Loprinzi C., Michalak J., Quella S.et al. Megestrol acetate for the prevention of hot flashes. N Engl J Med. 331:1994;347-352.
6. Quella S., Loprinzi C., Sloan J.et al. Long-term use of megestrol acetate by cancer survivors for the treatment of hot flashes. Cancer. 82:1998;1784-1788.
7. Bellini G, Venturini M, Mastro L, et al. Depot intramuscular medroxyprogesterone acetate vs. oral megestrol acetate for the treatment of hot flashes in breast cancer survivors: Results of GONO MIG-4 phase III trial. Proc Am Soc Clin Oncol 1999;18:abstract 2286.
8. Barton D., Loprinzi C., Quella S.et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol. 12:1998;155-158.
9. Loprinzi C, Kugler J, Sloan J, et al. Venlafaxine alleviates hot flashes: an NCCTG trial. ASCO 2000 Plenary Session and Proceedings 2000;19:abstract 4.
10. Morrison J., Martin D., Blair R.et al. The use of medroxyprogesterone acetate for relief of climacteric symptoms. Am J Obstet Gynecol. 138:1980;99-104.
11. Bullock J., Massey F., Gambrell R. Use of medroxyprogesterone acetate to prevent menopausal symptoms. Obstet Gynecol. 46(2):1975;16-168.
12. Lobo R., McCormick W., Singer F., Roy S. Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women. Obstet Gynecol. 63(1):1984;1-5.
13. American Hospital Formulary Service Medroxyprogesterone acetate. McEvoy G. Drug Information. 1998;2633-2637 American Society of Health-System Pharmacists, Bethesda, MD.
14. Abrams J., Parnes H., Aisner J. Current status of high dose progesterones on breast cancer. Semin Oncol 1990;17S:68-72.